Qiagen

19300 Germantown Rd , Germantown, MD 20874

Public
Healthcare & Pharmaceuticals - Biotechnology
around $100 - 500M
around 1K - 5K
(240) 686-7700
800-718-2056


QIAGEN is the leading provider of sample and assay technologies. Sample technologies are used to isolate DNA, RNA, and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis. We have developed and market more than 1500 consumable products and automated solutions. Our portfolio includes the FDA-approved and CE-marked digene HPV Test, which is regarded as the gold standard in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer. We sell these products to molecular diagnostics laboratories, academic research markets, leading pharmaceutical and biotechnology companies, as well as to customers in applied testing markets such as ... (Source: SEC reports)


Competitor - 1/8
Which company is more competitive with Qiagen?




202 Contacts at this company
Patricia Tonak
Human Resources Manager Marketing and Strategy Europe
Fitrina Budiwarman
Manufacturing Manager
John Rockwell
Manager Prodn Kit Assy Operations North America
Hina Patel
Regulatory Affairs Manager
Valerie Reposa
Senior Manager, Financial Reporting
Judy Palombi
Strategic Account Manager
Armelle Leviel
Clinical Marketing Manager
Hoi Tin
Project Manager
Eileen Daniels
Manager Customer Care

Sep 17, 2018 19:18:46
HILDEN, Germany & SALUGGIA, Italy--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE [...]

Sep 17, 2018 17:42:46
HILDEN, Germany & ANN ARBOR, Mich.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx  [...]

Sep 12, 2018 17:48:47
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that [...]

Sep 12, 2018 17:31:08
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that [...]

Sep 4, 2018 17:30:33
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. announces that it will initiate the repurchase of a second tranche of [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.